Joseph E. Schwartz, Ph.D.

  • Assistant Professor, Division of General Medicine
Contact Information: 

622 W. 168th Street
PH 9 Room 322
New York, NY 10032
Phone: 212-342-4487
jes2226@cumc.columbia.edu

Curriculum Vitae

Education

Graduate:
Ph.D., Sociology (1978), Harvard University, Cambridge, MA
M.A., Sociology (1977), Harvard University, Cambridge, MA
Visiting student, Sociology (1975), Oxford University, Oxford, England
Undergraduate:
B.A., Mathematics, Sociology (1972), Cornell University, Ithaca, NY

Research

Dr. Joseph Schwartz is an internationally recognized leader in the fields of cardiovascular behavioral medicine and quantitative methodology. He is an elected Fellow of the Society of Behavioral Medicine and the Academy of Behavioral Medicine Research, a member of the American Psychosomatic Society, American Society of Hypertension, North American Artery, and the former MacArthur Research Network on Socioeconomic Status and Health. He has been the Principal Investigator (PI) or Project Leader of numerous federally-funded research grants and co-investigator, biostatistician or statistical consultant on many more. Currently, he is the PI of an NHLBI program project grant (Psychosocial Factors and Cardiovascular Disease). Within the program project, he has led the Work Site Blood Pressure Study from 1991-2003 (59 publications in peer-reviewed journals) and, since then, the ongoing Masked Hypertension Study. He has also led the Data Management and Statistics Core of this, a second PPG, and a large U01 contract. His areas of statistical expertise include multilevel models for continuous and binary data (especially intensive repeated measures data), structural equation models, survival analysis, the impact of measurement and misclassification errors on statistical analyses, and receiver operating characteristic (ROC) curve analysis for the assessment of diagnostic biomarkers. He has considerable experience conducting and analyzing data from randomized controlled trials. He recently served on the Data Safety Monitoring Board for a smoking cessation RCT, and he is the biostatistician for two recently completed RCTs. Also, in collaboration with others, he has contributed to the collection and analysis of data pertaining to quality of life and depressive symptoms among patients with heart failure and other cardiovascular disease. He recently completed an R01 that involved the collection of 30-45 days of actigraphy data in a cohort of patients with acute coronary syndromes, and he has extensive experience analyzing 24-hour continuously ascertained data (ambulatory blood pressure, actigraphy, diary/EMA, HRV). He has successfully mentored many junior faculty members, including the K23 awards of Dr. Karina Davidson and 5 other early career researchers.
 
Selected Publications

  1. Schwartz JE, Stone AA. The analysis of real-time momentary data: A practical guide; in Stone AA, Shiffman S, Atienza AA, Nebeling L (eds): The science of real-time data capture: Self-report in health research. Oxford, Oxford University Press, 2007, pp 76-113.
  2. Pickering TG, Gerin W, Schwartz JE, Spruill TM, Davidson KW. Franz Volhard lecture: Should doctors still measure blood pressure? The missing patients with masked hypertension. J Hypertens, 2008;26:2259-2267.
  3. Davidson KW, Burg MM, Kronish IM, Shimbo D, Dettenborn L, Mehran R, Vorchheimer D, Clemow L, Schwartz JE, Lespérance F, and Rieckmann N. Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psych, 67(2010): 480-488. PMCID: PMC3058237.
  4. Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, Albanese G, Kronish I, Hegel M, Burg MM. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: Coronary Psychosocial Evaluation Studies randomized controlled trial. Arch Int Med, 170(2010): 600-608. PMCID: PMC2882253.
  5. Freedland KE, Mohr DC, Davidson KW, Schwartz JE. Usual and unusual care: Existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med, 73(2011): 323-335.
  6. Anglicheau D, Muthukumar T, Hummel A, Ding R, Sharma VK, Dadhania D, Seshan SV, Schwartz JE, Suthanthiran M. Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis. Transplantation 2012;93:1136-1146. PMCID: PMC3377557
  7. Shimbo D, Newman JD, Schwartz JE. Masked hypertension and prehypertension: Diagnostic overlap and interrelationships with left ventricular mass: The Masked Hypertension Study. Am J Hypertens 2012;25:664-671. PMCID: PMC3668422
  8. Edmondson D, Shaffer JA, Chaplin WF, Burg MM, Stone AA, Schwartz JE. Trait anxiety and trait anger measured by ecological momentary assessment and their correspondence with traditional trait questionnaires. J Res Pers. 2013;47:843-852. PMCID: PMC3815708
  9. Suthanthiran M, Schwartz JE, Ding R, al. E. Urinary-cell mRNA profile and acute cellular rejection in the kidney allografts. N Engl J Med 2013;369:20-31. PMCID: PMC3786188
  10. Ogedegbe G, Tobin JN, Fernandez S, Schwartz JE, Cassells A, Diaz-Gloster M,. Khalida C, Pickering TG. Counseling African Americans to control hypertension (CAATCH): Main results from a cluster-randomized clinical trial. Circulation. 2014;129:2044-51. NIHMSIS: NIHMS573121